Cargando…

Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases

BACKGROUND AND AIMS: To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China. METHODS: A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian-Guo, Zhu, Jian, Zhang, Yong-Hui, Chen, Yong-Sheng, Ding, Lu-Lu, Chen, Hai-Zhen, Shen, Ai-Guo, Wang, Gao-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418373/
https://www.ncbi.nlm.nih.gov/pubmed/34513745
http://dx.doi.org/10.2147/JHC.S321346
_version_ 1783748565460320256
author Chen, Jian-Guo
Zhu, Jian
Zhang, Yong-Hui
Chen, Yong-Sheng
Ding, Lu-Lu
Chen, Hai-Zhen
Shen, Ai-Guo
Wang, Gao-Ren
author_facet Chen, Jian-Guo
Zhu, Jian
Zhang, Yong-Hui
Chen, Yong-Sheng
Ding, Lu-Lu
Chen, Hai-Zhen
Shen, Ai-Guo
Wang, Gao-Ren
author_sort Chen, Jian-Guo
collection PubMed
description BACKGROUND AND AIMS: To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China. METHODS: A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. Mixed methods by active and passive follow-up were performed. Life table method was employed for survival analysis by SPSS22 software. Wilcoxon (Gehan) statistics was considered as a significant test. Relative survival was calculated by using SURV software, and its annual percent change (APC) was estimated by the Joinpoint Regression Program. RESULTS: The overall observed survival (OS) rates of 1-, 5-, 10-, and 20-year rates from the data series were 18.51%, 6.28%, 4.03%, and 2.84%, and their relative survival (RS) rates were 18.88%, 6.95%, 4.96%, and 4.49%, respectively. For 24,338 male cases, the 5-year OS and RS rates were 5.93% and 6.54%, and for 8218 female cases, 7.34% and 8.15%, respectively, with P values less than 0.01. Survival rates of liver cancer from three 15-year periods of 1972–1986, 1987–2001, and 2002–2016 have increased significantly, with 5-year OS rates of 2.02%, 4.40%, and 10.76%, 5-year RS rates of 2.18%, 4.83%, and 12.18%; 10-year OS and RS rates of 0.95%, 3.00%, and 7.02%, vs 1.13%, 3.65%, and 8.96%, respectively, showing a very significant upward trend (P<0.01). There are significant differences among age groups (P<0.01): those aged 55–64 demonstrated the best OS and RS rates of 5-year, being 8.44% and 9.09%, respectively. CONCLUSION: There are significant gender and age differences in the survival rate of liver cancer in Qidong. RWD indicates the relative lower survival rate of liver cancer in this area, but great improvement has been achieved over the past decades.
format Online
Article
Text
id pubmed-8418373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84183732021-09-09 Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases Chen, Jian-Guo Zhu, Jian Zhang, Yong-Hui Chen, Yong-Sheng Ding, Lu-Lu Chen, Hai-Zhen Shen, Ai-Guo Wang, Gao-Ren J Hepatocell Carcinoma Original Research BACKGROUND AND AIMS: To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China. METHODS: A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. Mixed methods by active and passive follow-up were performed. Life table method was employed for survival analysis by SPSS22 software. Wilcoxon (Gehan) statistics was considered as a significant test. Relative survival was calculated by using SURV software, and its annual percent change (APC) was estimated by the Joinpoint Regression Program. RESULTS: The overall observed survival (OS) rates of 1-, 5-, 10-, and 20-year rates from the data series were 18.51%, 6.28%, 4.03%, and 2.84%, and their relative survival (RS) rates were 18.88%, 6.95%, 4.96%, and 4.49%, respectively. For 24,338 male cases, the 5-year OS and RS rates were 5.93% and 6.54%, and for 8218 female cases, 7.34% and 8.15%, respectively, with P values less than 0.01. Survival rates of liver cancer from three 15-year periods of 1972–1986, 1987–2001, and 2002–2016 have increased significantly, with 5-year OS rates of 2.02%, 4.40%, and 10.76%, 5-year RS rates of 2.18%, 4.83%, and 12.18%; 10-year OS and RS rates of 0.95%, 3.00%, and 7.02%, vs 1.13%, 3.65%, and 8.96%, respectively, showing a very significant upward trend (P<0.01). There are significant differences among age groups (P<0.01): those aged 55–64 demonstrated the best OS and RS rates of 5-year, being 8.44% and 9.09%, respectively. CONCLUSION: There are significant gender and age differences in the survival rate of liver cancer in Qidong. RWD indicates the relative lower survival rate of liver cancer in this area, but great improvement has been achieved over the past decades. Dove 2021-08-31 /pmc/articles/PMC8418373/ /pubmed/34513745 http://dx.doi.org/10.2147/JHC.S321346 Text en © 2021 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Jian-Guo
Zhu, Jian
Zhang, Yong-Hui
Chen, Yong-Sheng
Ding, Lu-Lu
Chen, Hai-Zhen
Shen, Ai-Guo
Wang, Gao-Ren
Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
title Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
title_full Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
title_fullStr Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
title_full_unstemmed Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
title_short Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
title_sort liver cancer survival: a real world observation of 45 years with 32,556 cases
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418373/
https://www.ncbi.nlm.nih.gov/pubmed/34513745
http://dx.doi.org/10.2147/JHC.S321346
work_keys_str_mv AT chenjianguo livercancersurvivalarealworldobservationof45yearswith32556cases
AT zhujian livercancersurvivalarealworldobservationof45yearswith32556cases
AT zhangyonghui livercancersurvivalarealworldobservationof45yearswith32556cases
AT chenyongsheng livercancersurvivalarealworldobservationof45yearswith32556cases
AT dinglulu livercancersurvivalarealworldobservationof45yearswith32556cases
AT chenhaizhen livercancersurvivalarealworldobservationof45yearswith32556cases
AT shenaiguo livercancersurvivalarealworldobservationof45yearswith32556cases
AT wanggaoren livercancersurvivalarealworldobservationof45yearswith32556cases